首页 | 本学科首页   官方微博 | 高级检索  
     

氟脲嘧啶微粒-壳聚糖微敏性水凝胶复合释药系统的制备
引用本文:昝佳,朱德权,谭丰苹,蒋国强,林莹,丁富新.氟脲嘧啶微粒-壳聚糖微敏性水凝胶复合释药系统的制备[J].中国化学工程学报,2006,14(2):235-241.
作者姓名:昝佳  朱德权  谭丰苹  蒋国强  林莹  丁富新
作者单位:[1]Department of Chemical Engineering, Tsinghua University, Beijing 100084, China [2]School of Pharmacy, Tianjin University, Tianjin 300072, China
基金项目:国家自然科学基金,Research Foundation of the Ministry of Education of China
摘    要:The auto-gelling and drug release properties of the thermosensitive chitosan-β-glycerophosphate formulation were investigated. According to rheological study, gelation lag time of chitosan/β-glycerophosphate (GP) solutions varied from 2 to 60min with different deacetylation degree of chitosan, pH, gelation temperature, and the particles in the sol. The gelation properties were also found to influence the release profilles of a hydrophilic drug, 5-fluorouracil (5-FU). Morphological examination by scanning electron microphotography demonstrated that large "pores" occurred during the gel-forming process, which created hydrophilic environment and led to the rapid initial release of the drug (85% in f'LrSt 8h). Poly-3-hydroxybutyrate (PHB), a biodegradable material, was applied here as scaffold to capture 5-FU into microparticles with high encapsulation efficiency by solvent-nonsolvent method. Combination of these microparticles into the chitosan-β-GP formulation could drop the rapid initial release from 85% down to 29% in the optimized PHB content (75%, by mass). The release could sustain for about 10 months. Tiffs study provided an understanding of the potential of injectable implant using thermosensitive chitosan-β-GP formulation containing PHB based particles for the water soluble drugs that need the property of long-term delivery.

关 键 词:氟脲嘧啶微粒-壳聚糖  微敏性水凝胶  复合释药系统  制备  药物释放
收稿时间:2005-03-08
修稿时间:2005-03-082006-02-13

Preparation of Thermosensitive Chitosan Formulations Containing 5-Fluorouracil/Poly-3-hydroxybutyrate Microparticles Used as Injectable Drug Delivery System
Jia ZAN, Dequan ZHU, Fengping TAN, Guoqiang JIANG, Ying LIN,Fuxin DING,.Preparation of Thermosensitive Chitosan Formulations Containing 5-Fluorouracil/Poly-3-hydroxybutyrate Microparticles Used as Injectable Drug Delivery System[J].Chinese Journal of Chemical Engineering,2006,14(2):235-241.
Authors:Jia ZAN  Dequan ZHU  Fengping TAN  Guoqiang JIANG  Ying LIN  Fuxin DING  
Affiliation:Department of Chemical Engineering, Tsinghua University, Beijing 100084, China;School of Pharmacy, Tianjin University, Tianjin 300072, China
Abstract:The auto-gelling and drug release properties of the thermosensitive chitosan-β-glycerophosphate formulation were investigated. According to rheological study, gelation lag time of chitosan/β-glycerophosphate (GP)solutions varied from 2 to 60min with different deacetylation degree of chitosan, pH, gelation temperature, and the particles in the sol. The gelation properties were also found to influence the release profiles of a hydrophilic drug,5-fluorouracil (5-FU). Morphological examination by scanning electron microphotography demonstrated that large "pores" occurred during the gel-forming process, which created hydrophilic environment and led to the rapid initial release of the drug (85% in first 8h). Poly-3-hydroxybutyrate (PHB), a biodegradable material, was applied here as scaffold to capture 5-FU into microparticles with high encapsulation efficiency by solvent-nonsolvent method.Combination of these microparticles into the chitosan-β-GP formulation could drop the rapid initial release from 85% down to 29% in the optimized PHB content (75%, by mass). The release could sustain for about 10 months.This study provided an understanding of the potential of injectable implant using thermosensitive chitosan-β-GP formulation containing PHB based particles for the water soluble drugs that need the property of long-term delivery.
Keywords:hydrogel  chitosan  injectables  microparticle  drug release
本文献已被 CNKI 维普 万方数据 ScienceDirect 等数据库收录!
点击此处可从《中国化学工程学报》浏览原始摘要信息
点击此处可从《中国化学工程学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号